Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seppo W Langer

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 27, 2021
Semiautomatic Tumor Delineation for Evaluation of <sup>64</sup>Cu-DOTATATE PET/CT in Patients with Neuroendocrine Neoplasms: Prognostication Based on Lowest Lesion Uptake and Total Tumor VolumeEsben Andreas Carlsen, Camilla Bardram Johnbeck, Mathias Loft, et al.
Molecular Imaging and Biology|February 15, 2022
Activity Dose Reduction in <sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Impact on Image Quality and Lesion Detection AbilityMathias Loft, Esben A Carlsen, Camilla B Johnbeck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 11, 2023
An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose <sup>64</sup>Cu-DOTATATE PET Imaging in Patients with Neuroendocrine NeoplasmsMathias Loft, Claes N Ladefoged, Camilla B Johnbeck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2020
<sup>18</sup>F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A Prospective 10-Year Follow-up StudyTina Binderup, Ulrich Knigge, Camilla Bardram Johnbeck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2016
Early lesion-specific (18)F-FDG PET response to chemotherapy predicts time to lesion progression in locally advanced non-small cell lung cancerLotte Nygård, Ivan R Vogelius, Barbara M Fischer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2026
Malignancy Detection Rates of [<sup>68</sup>Ga]Ga-SSO120 PET/CT in Patients with Small Cell Lung Cancer and Large Cell Neuroendocrine Lung CancerTine N Christensen, Seppo W Langer, Danijela Dejanovic, et al.
American Journal of Nuclear Medicine and Molecular Imaging|April 13, 2016
(68)Ga-DOTATOC PET and gene expression profile in patients with neuroendocrine carcinomas: strong correlation between PET tracer uptake and gene expression of somatostatin receptor subtype 2Ingrid H Olsen, Seppo W Langer, Birgitte H Federspiel, et al.
Current Treatment Options in Oncology|April 1, 2022
Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine NeoplasmsPernille Holmager, Seppo W Langer, Andreas Kjaer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2015
64Cu-DOTATATE for Noninvasive Assessment of Atherosclerosis in Large Arteries and Its Correlation with Risk Factors: Head-to-Head Comparison with 68Ga-DOTATOC in 60 PatientsCatarina Malmberg, Rasmus S Ripa, Camilla B Johnbeck, et al.
Cancers|January 11, 2024
Recurrence-Free Survival and Disease-Specific Survival in Patients with Pancreatic Neuroendocrine Neoplasms: A Single-Center Retrospective Study of 413 PatientsStine Møller, Seppo W Langer, Cecilie Slott, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 27, 2021
Semiautomatic Tumor Delineation for Evaluation of <sup>64</sup>Cu-DOTATATE PET/CT in Patients with Neuroendocrine Neoplasms: Prognostication Based on Lowest Lesion Uptake and Total Tumor VolumeEsben Andreas Carlsen, Camilla Bardram Johnbeck, Mathias Loft, et al.
Molecular Imaging and Biology|February 15, 2022
Activity Dose Reduction in <sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Impact on Image Quality and Lesion Detection AbilityMathias Loft, Esben A Carlsen, Camilla B Johnbeck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 11, 2023
An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose <sup>64</sup>Cu-DOTATATE PET Imaging in Patients with Neuroendocrine NeoplasmsMathias Loft, Claes N Ladefoged, Camilla B Johnbeck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2020
<sup>18</sup>F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A Prospective 10-Year Follow-up StudyTina Binderup, Ulrich Knigge, Camilla Bardram Johnbeck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2016
Early lesion-specific (18)F-FDG PET response to chemotherapy predicts time to lesion progression in locally advanced non-small cell lung cancerLotte Nygård, Ivan R Vogelius, Barbara M Fischer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2026
Malignancy Detection Rates of [<sup>68</sup>Ga]Ga-SSO120 PET/CT in Patients with Small Cell Lung Cancer and Large Cell Neuroendocrine Lung CancerTine N Christensen, Seppo W Langer, Danijela Dejanovic, et al.
American Journal of Nuclear Medicine and Molecular Imaging|April 13, 2016
(68)Ga-DOTATOC PET and gene expression profile in patients with neuroendocrine carcinomas: strong correlation between PET tracer uptake and gene expression of somatostatin receptor subtype 2Ingrid H Olsen, Seppo W Langer, Birgitte H Federspiel, et al.
Current Treatment Options in Oncology|April 1, 2022
Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine NeoplasmsPernille Holmager, Seppo W Langer, Andreas Kjaer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2015
64Cu-DOTATATE for Noninvasive Assessment of Atherosclerosis in Large Arteries and Its Correlation with Risk Factors: Head-to-Head Comparison with 68Ga-DOTATOC in 60 PatientsCatarina Malmberg, Rasmus S Ripa, Camilla B Johnbeck, et al.
Cancers|January 11, 2024
Recurrence-Free Survival and Disease-Specific Survival in Patients with Pancreatic Neuroendocrine Neoplasms: A Single-Center Retrospective Study of 413 PatientsStine Møller, Seppo W Langer, Cecilie Slott, et al.
Pageof 12